RECURRENT ASTROCYTOMA, IDH-MUTANT, GRADE 4
Clinical trials for RECURRENT ASTROCYTOMA, IDH-MUTANT, GRADE 4 explained in plain language.
Never miss a new study
Get alerted when new RECURRENT ASTROCYTOMA, IDH-MUTANT, GRADE 4 trials appear
Sign up with your email to follow new studies for RECURRENT ASTROCYTOMA, IDH-MUTANT, GRADE 4, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Fat stem cells take on brain tumors in new trial
Disease control Recruiting nowThis early-stage trial tests if stem cells taken from body fat are safe for people with glioblastoma or astrocytoma that has returned after standard treatment. About 20 adults will receive the cells directly into the brain during surgery. The goal is to find the best dose and see…
Matched conditions: RECURRENT ASTROCYTOMA, IDH-MUTANT, GRADE 4
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for aggressive brain tumors: drug combo shows promise before surgery
Disease control Recruiting nowThis study tests two drugs, GI-102 and pembrolizumab, given before surgery to people whose aggressive brain cancer (glioblastoma) has returned. The goal is to see if these drugs can shrink the tumor and help the immune system fight the cancer. About 36 adults will take part, and …
Matched conditions: RECURRENT ASTROCYTOMA, IDH-MUTANT, GRADE 4
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Engineered immune cells target aggressive brain tumors in new trial
Disease control Recruiting nowThis early-stage trial tests a new treatment for people with high-grade gliomas that have returned or worsened. The therapy uses the patient's own immune cells, modified in a lab to recognize and attack tumor cells, and delivers them directly into the brain. The main goals are to…
Matched conditions: RECURRENT ASTROCYTOMA, IDH-MUTANT, GRADE 4
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 11, 2026 20:53 UTC